Apex Biotechnology Corp. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced total revenue was TWD 524.934 million compared to TWD 470.455 million a year ago. Operating income was TWD 34.660 million compared to TWD 44.700 million a year ago. Net income was TWD 21.738 million compared to TWD 17.058 million a year ago. Basic earnings per share was TWD 0.22 compared to TWD 0.17 a year ago. Diluted earnings per share was TWD 0.2 compared to TWD 0.17 a year ago.